-
Oregon families grapple with explaining school shooting to children
-
Tents spring up in Lisbon as Portugal housing protests spread
-
Israeli settlers attack European diplomats, beat French mayor
-
'Best in world' Yamal powers Barca to Betis rout, Atletico strike late
-
Town hall in Limoges 'largely lost' to blaze set during French protests
-
El Salvador's Bukele puts conditions on early release of gang prisoners
-
US goes on the offensive in central Asia
-
Fire rages at town hall in France's Limoges after protests: authorities
-
Emotional Lions come up short in Champions Cup as tributes paid to Andrews
-
Unstoppable Barca thrash Betis to extend perfect start
-
Diaz dazzles as Bayern batter Leipzig to go top
-
Maresca faces anxious wait over Haaland injury scare
-
Inter move clear at Serie A summit with Bologna win
-
PSG fight back to beat Strasbourg after Dembele penalty miss
-
Liverpool still have 'lots to improve', says match-winner Isak
-
Looting, blazes and clashes in France amid nationwide protests
-
Looters ransack shops during France cost-of-living protests
-
Walsh breaks her own 50 free world short course record
-
Leinster thump Clermont as grieving Lions set for Champions Cup debut
-
Haaland brace extends Man City's winning start in Premier League
-
Haaland stars in Man City win, Liverpool beat Brentford
-
'Special' Ombudsman storms to victory in Champion Stakes
-
Dortmund go top despite Union Berlin stalemate
-
Brazil's right embraces election betting odds amid polls skepticism
-
Venezia upset Napoli for first Serie A win of season
-
Four more Ebola cases detected in Kenya, bringing total to seven
-
Glasgow and Bulls win as grieving Lions set for Champions Cup debut
-
Clashes erupt in France as protesters vow to make government 'tremble'
-
Smiling pope returns to Vatican after cancer surgery
-
Chwalinska downs Swiatek to set up Wuhan final with world number 170 Kartal
-
In-form Atletico scrape late win at Espanyol
-
Chacarra takes lead as McIlroy falls away in Delhi
-
Rabada returns as S.Africa seek to bounce back against Australia
-
Neto double gives Chelsea win marred by Martinez injury
-
Zverev, Medvedev ousted with Spaniards to clash for Shanghai title
-
'Cockroach' party founder released from Indian police custody
-
French protesters clash with police during nationwide demonstrations
-
Nepal floods 'defining moment' for climate action: UN
-
Zelensky says Trump could lift more Russia sanctions
-
Albanian capital sees fifth straight day of violent clashes
-
Jayawardene quits as coach of five-time IPL winners Mumbai
-
Leaders weigh 'huge benefit', risks of AI for global economy
-
World number 170 Kartal battles past Ostapenko to reach Wuhan final
-
Zverev stunned by Davidovich Fokina in Shanghai semi-finals
-
Pope to return to Vatican after cancer surgery
-
France faces day of cost-of-living protests
-
Haze triggers highest-level alert in parts of Southeast Asia
-
Zelensky says Trump waiving sanctions 'rewards' Putin, warns Moscow wants 'blackout' in Ukraine
-
I'd have left Real Madrid if I were Vinicius, says Mourinho
-
Noosha Aubel: vezetői kudarc új kezdet helyett – alkalmas-e Potsdam polgármestere a tisztsége betöltésére?
Trump signs order to fast-track research on psychedelic drugs
US President Donald Trump on Saturday announced an easing of restrictions on research into psychedelic drugs -- such as so-called "magic mushrooms" -- that have shown promise in treating people with mental health conditions.
Flanked by US Health Secretary Robert F. Kennedy Jr, top medical officials and podcaster Joe Rogan, who has pushed for access to the drugs, Trump signed an executive order that would help federal researchers cut through the red tape to allow for quicker studies.
The president said the order would "clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA (Food and Drug Administration) and the Department of Veterans Affairs and facilitate fast rescheduling of any psychedelic drugs that become FDA approved."
Currently, many psychedelics including LSD and psilocybin ("magic mushrooms") are classified -- or "scheduled" -- as having high abuse and addiction potential, and are not approved for medical use, limiting the ability for scientists to study them.
If the FDA, which is charged with regulating pharmaceuticals in the United States, officially finds a medical benefit for some of the psychedelics, they could be rescheduled, allowing for greater clinical use.
The order only provides for accelerated research and does not immediately require law enforcement authorities to reclassify the drugs, meaning therapeutic use will not expand immediately.
In recent years, there has been a growing push to research the effects of the drugs in treating people -- especially war veterans -- with difficult anxiety and depression cases, especially those who had experienced traumatic stress.
Many veterans and other patients have complained that traditional antidepressant cocktails not only fail to work but change their personalities in ways that alienate them from their friends and family.
In 2023, 6,398 veterans took their own lives, the Department of Veterans Affairs said.
During the signing ceremony at the White House, Trump pointed to one drug called ibogaine, claiming patients who had taken it "experienced an 80 to 90 percent reduction in symptoms of depression and anxiety within one month."
"Can I have some, please?" he joked.
The full extent of the benefits and potential side effects of psychedelic medications is not yet known, since research has been restricted.
While many are thought to show promising mental health benefits, there are risks. Ibogaine, for instance, is thought to potentially damage the heart.
If you are a US veteran in need of help, or concerned about one, you can dial 988 and press 1, or visit www.veteranscrisisline.net.
L.AbuAli--SF-PST